Stock FPH FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fisher & Paykel Healthcare Corporation Limited

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

End-of-day quote New Zealand S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
29.5 NZD +3.51% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +4.13% +25.00%
May. 29 Fisher & Paykel Healthcare Corporation Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
May. 29 New Zealand Shares Flat; Fisher & Paykel Healthcare's Fiscal 2024 Net Profit Falls MT

Valuation

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 17,455 18,494 14,056 15,436 14,979 17,227 - -
Enterprise Value (EV) 1 17,413 18,191 13,835 15,398 14,979 17,199 17,196 17,150
P/E ratio 61.3 x 35.5 x 37.5 x 62 x 113 x 50.6 x 42.1 x 35 x
Yield 0.91% 1.18% 1.62% 1.52% - 1.49% 1.66% 1.83%
Capitalization / Revenue 13.8 x 9.38 x 8.36 x 9.76 x 8.59 x 8.81 x 7.91 x 7.11 x
EV / Revenue 13.8 x 9.23 x 8.23 x 9.74 x 8.59 x 8.79 x 7.89 x 7.08 x
EV / EBITDA 40.5 x 23.1 x 23 x 35.7 x - 29.7 x 25.4 x 21.5 x
EV / FCF 116 x 41.3 x 74.4 x 572 x - 55.6 x 64.6 x 48.2 x
FCF Yield 0.87% 2.42% 1.34% 0.17% - 1.8% 1.55% 2.07%
Price to Book 18.1 x 12.2 x 8.37 x 8.8 x - 9.21 x 8.45 x 7.64 x
Nbr of stocks (in thousands) 574,571 576,122 577,269 579,219 583,964 583,980 - -
Reference price 2 30.38 32.10 24.35 26.65 25.65 29.50 29.50 29.50
Announcement Date 6/28/20 5/26/21 5/24/22 5/25/23 5/28/24 - - -
1NZD in Million2NZD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net sales 1 1,264 1,971 1,682 1,581 1,743 1,956 2,179 2,423
EBITDA 1 430.2 785.8 601.6 431.2 - 578.7 678.3 797.4
EBIT 1 379.3 712.3 505.6 332.2 373.4 461 556 668.2
Operating Margin 30.02% 36.14% 30.06% 21.01% 21.43% 23.57% 25.51% 27.58%
Earnings before Tax (EBT) 1 370.5 718.2 504.2 328 235.7 454.6 551.3 668
Net income 1 287.3 524.2 376.9 250.3 132.6 340.1 409.8 491.1
Net margin 22.73% 26.59% 22.41% 15.83% 7.61% 17.38% 18.81% 20.27%
EPS 2 0.4960 0.9040 0.6500 0.4300 0.2262 0.5834 0.7012 0.8423
Free Cash Flow 1 150.7 440.6 185.9 26.9 - 309.1 266.1 355.6
FCF margin 11.93% 22.35% 11.05% 1.7% - 15.8% 12.21% 14.68%
FCF Conversion (EBITDA) 35.03% 56.07% 30.9% 6.24% - 53.41% 39.24% 44.6%
FCF Conversion (Net income) 52.45% 84.05% 49.32% 10.75% - 90.9% 64.94% 72.4%
Dividend per Share 2 0.2750 0.3800 0.3950 0.4050 - 0.4392 0.4910 0.5406
Announcement Date 6/28/20 5/26/21 5/24/22 5/25/23 5/28/24 - - -
1NZD in Million2NZD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2 2026 S1 2026 S2
Net sales 1 692.8 910.2 1,061 900 781.7 690.6 890.5 803.7 939.1 900.8 1,061 - -
EBITDA - - - 348.4 253.2 - 254 - - - - - -
EBIT 1 213.3 309.2 403.1 302.4 203.2 126.7 205.5 152.6 220.8 184.6 277.7 - -
Operating Margin 30.79% 33.97% 37.99% 33.6% 25.99% 18.35% 23.08% 18.99% 23.51% 20.49% 26.17% - -
Earnings before Tax (EBT) 1 210.8 313 - 301.1 203.1 114.3 213.7 140.6 95.1 177.8 273.6 - -
Net income 1 166.1 225.5 - 221.8 155.1 95.9 154.4 107.3 25.3 133.4 199.8 - -
Net margin 23.98% 24.77% - 24.64% 19.84% 13.89% 17.34% 13.35% 2.69% 14.81% 18.83% - -
EPS 2 - 0.3890 0.5150 0.3830 0.2670 0.1660 0.2640 0.1850 0.0420 0.2267 0.3490 0.3300 0.3200
Dividend per Share 2 0.1550 0.1600 - 0.1700 0.2250 0.1750 0.2250 0.1800 - 0.1900 0.2800 - -
Announcement Date 6/28/20 11/24/20 5/26/21 11/24/21 5/24/22 11/28/22 5/25/23 11/28/23 5/28/24 - - - -
1NZD in Million2NZD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 - - - - - - - -
Net Cash position 1 42.2 303 222 37.7 - 28.8 31.7 77.7
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 151 441 186 26.9 - 309 266 356
ROE (net income / shareholders' equity) 30.5% 42% 23.6% 19.1% - 18.6% 20.9% 22.9%
ROA (Net income/ Total Assets) 21.8% 29.9% 18% 15.2% - 15% 16.4% 17.8%
Assets 1 1,321 1,755 2,091 1,647 - 2,268 2,496 2,756
Book Value Per Share 2 1.680 2.640 2.910 3.030 - 3.200 3.490 3.860
Cash Flow per Share 2 0.5600 1.080 0.5600 0.4100 - 0.8400 0.8900 1.000
Capex 1 171 185 138 188 - 145 231 224
Capex / Sales 13.51% 9.37% 8.23% 11.88% - 7.42% 10.62% 9.26%
Announcement Date 6/28/20 5/26/21 5/24/22 5/25/23 5/28/24 - - -
1NZD in Million2NZD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fisher & Paykel Healthcare Corporation Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
29.5 NZD
Average target price
26.11 NZD
Spread / Average Target
-11.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED Stock Fisher & Paykel Healthcare Corporation Limited
+25.00% 10.57B
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.24B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.76% 29.99B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-5.38% 23.69B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. FPH Stock
  4. Financials Fisher & Paykel Healthcare Corporation Limited